Lv3
320 积分 2025-07-31 加入
高选择性RET-TKI不良反应管理专家共识（2026版）
5小时前
已完结
抗体药物偶联物治疗肺癌不良反应多学科管理专家共识（2025版）
13天前
已完结
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non–Small Cell Lung Cancer The HARMONi-A Randomized Clinical Trial
16天前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
1个月前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
1个月前
已关闭
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)
1个月前
已完结
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)
1个月前
已关闭
[Clouds move aside to pour the moonlight: the past and present of antiphospholipid syndrome]
3个月前
已完结
How I diagnose and treat acute infection–associated purpura fulminans
3个月前
已完结
Dose-dependent pharmacological mechanisms within the Neuroscience-based Nomenclature: a new concept to facilitate neuroscience-based prescribing
5个月前
已完结
皖公网安备34019202002308
